Synthetic antioxidant l-ergothioneine safe as a novel food for pregnant women and children: EFSA

e93600d1-0d90-41a7-8135-378c762211dcarticleimage.jpg

24 Nov 2017 --- The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has concluded that synthetic l-ergothioneine is safe under the proposed uses and use levels for the groups of the population which had been excluded by the applicant in the original application. Following a request from the European Commission, EFSA confirmed the safety of the powerful antioxidant for groups including infants, young children (i.e. toddlers), pregnant women and breastfeeding women.

On 26 October, 2016, the EFSA NDA panel adopted the scientific opinion on the safety of synthetic l-ergothioneine as a novel food pursuant to Regulation (EC) No 258/97.

In performing the safety assessment of the novel food, the NDA panel considered the proposed uses (i.e. food ingredient added to alcohol-free beverages; milk; “fresh” dairy products; cereal bars and chocolate; food supplements) and the proposed target population (i.e. children above 3 years of age and the general adult population, with the exception of pregnant and breastfeeding women).

Detailed information on the safety assessment of synthetic l-ergothioneine is provided in the published opinion which informs on the specifications of the novel food, its stability, the production process, the anticipated intake/extent of use in the proposed target population, nutritional information of the novel food, microbiological information, toxicological information (including absorption, distribution, metabolism and excretion), human studies and potential allergenicity of the novel food.

In 2016, the NDA panel considered a no-observed-adverse-effect level (NOAEL) of 800 mg/kg body weight (bw) per day of the novel food. Taking into account this NOAEL and the maximum estimated intake levels for l-ergothioneine from all sources (i.e. fortified foods, food supplements and background diet) of 1.7 mg/kg bw per day for adults and of 3.7 mg/kg bw per day for children, the panel concluded that the margins of safety of 470 for adults (excluding pregnant and breastfeeding women) and of 216 for children above 3 years of age are sufficient.

Findings extend to additional groups
For the latest assessment, intake estimates were calculated for the specified groups and the following maximum anticipated daily intakes of l-ergothioneine from the NF, in addition to the background diet, were calculated: 2.82 mg/kg body weight (bw) per day for infants, 3.39 mg/kg bw per day for toddlers and 1.31 mg/kg bw per day for adults including pregnant and breastfeeding women.

The panel states that based on the overall toxicological data, the no-observed-adverse-effect level (NOAEL) of 800 mg/kg bw per day as established in the original assessment also pertains to pregnant and breastfeeding women as well as to young children (i.e., toddlers) and infants.

The corresponding margins of exposure (i.e., the ratio between the NOAEL and the maximum anticipated daily intakes) are 284 for infants, 236 for young children and 610 for pregnant and breastfeeding women. These margins of exposure are considered sufficient.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Claiming concentration? Red Bull cautioned by UK advertising watchdog for “misleading” health claim

17 Jan 2019 --- UK advertising watchdog, the Advertising Standards Authority (ASA), has banned a poster for the energy drink Red Bull for reportedly implying that Red Bull has a beneficial impact on health, in particular, focus and concentration. Suggesting a product aids focus and concentration is a health claim, and therefore must comply with the claims authorized on the EU register. This is According to Regulation (EC) 1924/2006 on nutrition and health claims made on foods. Health claims are defined as those that state, suggest or imply a relationship between a food, or ingredient and health.

Health & Nutrition News

Microbiome holds potential for treating milk allergy, mice study finds

16 Jan 2019 --- Gut microbes from healthy infant donors transplanted into mice prevented allergic reactions to milk, while gut microbes from infant donors with milk allergies failed to do the same, according to a Chicago University study. Supported by the US National Institutes of Health (NIH) and published in Nature Medicine, the study findings suggest that gut microbes can significantly affect allergic responses to foods.

Health & Nutrition News

A failing strategy? Gestational diabetes risk not lowered through reduced weight gain research finds

15 Jan 2019 --- Conventional ways to prevent gestational diabetes mellitus are ineffective and its appearance possibly depends on each individual’s health, according to a recent Pennington Biomedical study. The results found that moms-to-be who ate healthier and less, and increased their physical activity, developed gestational diabetes at about the same rates as women who didn't follow the same lifestyle. The researchers now believe there may be different types of gestational diabetes that warrant different approaches to treatment and prevention.

Health & Nutrition News

Unhealthy demographic targeting? Bulk of black and Hispanic teens US food TV advertising budget goes on junk options

15 Jan 2019 --- Of the US$1.1 billion spent on advertising to black and Hispanic teens – via Spanish-language and black-targeted TV programming – over 80 percent was channeled to adverts for fast food restaurants and by food and beverage companies marketing unhealthy food. This is according to a report from the Rudd Center for Food Policy & Obesity at the University of Connecticut.

Health & Nutrition News

Has the haze lifted? As cannabis-derivatives get the green light, NPD expansion is set to grow

15 Jan 2019 --- Cannabis-derivatives, such as hemp and cannabidiol (CBD), have been increasingly cropping up on ingredients lists in the US and elsewhere. A recent ruling, which came as the US Government launched its farm bill in December 2018, alleviates hemp of its illegal status, which is expected to spur further innovation. Part one of this NutritionInsight two-part report into cannabis-derived products in the nutrition and food industry explored the softening regulatory environment. Part two considers how the industry may respond to the opportunities that such regulation shifts may bring to the US and Canada, for example.

More Articles
URL : http://www.nutritioninsight.com:80/news/synthetic-antioxidant-l-ergothioneine-safe-as-a-novel-food-for-pregnant-women-and-children-efsa.html